Rodrigo Entrialgo‐Cadierno

Statistics

Publications

Citations

301

H-Index

Active since

2018

Affiliations

Centro de Investigación Biomédica en Red de Cáncer(Current)

Navarre Institute of Health Research

Universidad de Navarra

Clinica Universidad de Navarra

Stanford University

Rodrigo Entrialgo‐Cadierno is an author at Centro de Investigación Biomédica en Red de Cáncer specializing in oncogenic signaling pathways, oncology, and medicine.

ORCID

Publications per year

2018–2024

Publications

De novo biosynthesis of myricetin, kaempferol and quercetin in Streptomyces albus and Streptomyces coelicolor

Laura Marín, Ignacio Gutiérrez‐del‐Río, Rodrigo Entrialgo‐Cadierno et al. · PLoS ONE · 2018 · 105 citations · Full text

Pharmacy, Biochemistry, Biotechnology +16

The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

Karmele Valencia, Oihane Erice, Kaja Kostyrko et al. · Journal of Clinical Investigation · 2019 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17

FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted

Adrián Vallejo, Oihane Erice, Rodrigo Entrialgo‐Cadierno et al. · Journal of Hepatology · 2021 · 49 citations · Full text

Medicine, Molecular Biology, Oncology +17

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

Oihane Erice, Shruthi Narayanan, Iker Feliu et al. · Clinical Cancer Research · 2023 · 34 citations

Medicine, Molecular Biology, Oncology +17

The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

Rodrigo Entrialgo‐Cadierno, Cristina Cueto‐Ureña, Connor Welch et al. · Molecular Cancer · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacology +12

1–5 of 7